Details

NameSymbolSector
KIMIA BIOSCIENCES LIMITEDKIMIABLPharmaceuticals
Open
45.14
High
45.15
Low
41.11
Close
43
Volume
14656
Exchange
bse
Time
14/08

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Kimia Biosciences is  
None
Estimated Stoploss of Kimia Biosciences is ₹  
45.15
Kimia Biosciences has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Kimia Biosciences is  
Unpredictableℹ
. 

Trend

Kimia Biosciences is in  
Strong Downtrendℹ
. 
Price of Kimia Biosciences is  
Downℹ
 by  

26.22

%. 
Target
Buy @ 

41.98

Sell @ 

72.96

Volume

The trade volumes of Kimia Biosciences have become  
Deficientℹ
The volume trend for Kimia Biosciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Kimia Biosciences is  

Down

 by  

24.88

% 

Valuation

The current market price of Kimia Biosciences is  
Undervaluedℹ

Financials

Balance
The balance sheet of Kimia Biosciences is:  

Balanced

Cashflow
Kimia Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

51.22% i.e. ₹ 21cr earned in operatingℹ
9.76% i.e. ₹ 4cr spent in investingℹ
39.02% i.e. ₹ 16cr spent in financingℹ
0% in otherℹ
Kimia Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 14cr earned in operatingℹ
3.57% i.e. ₹ 1cr spent in investingℹ
46.43% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Kimia Biosciences is  

₹ 24cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Kimia Biosciences Losses increased by:  

100

% and Income is Down by:  

36.84

% 

(*Jun 2025)

The income of Kimia Biosciences is  

₹ 38cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Kimia Biosciences Profit is down by:  

75

% and Income is Up by:  

26.67

% 

(*Mar 2025)

The income of Kimia Biosciences is  

₹ 30cr

 and  

Profit

 is :  

₹ 4cr

(*Dec 2024)

Kimia Biosciences Profit is up by:  

300

% and Income is Up by:  

7.14

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.